U.S. Markets closed

The Spectranetics Corporation (SPNC)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
38.450.00 (0.00%)
At close: 4:00PM EDT
People also watch

The Spectranetics Corporation

9965 Federal Drive
Colorado Springs, CO 80921
United States

IndustryMedical Appliances & Equipment
Full Time Employees960

Key Executives

Mr. Scott William DrakeChief Exec. Officer, Pres and Director1.41MN/A49
Ms. Stacy Powell McMahanChief Financial Officer1.02MN/A53
Mr. Shahriar MatinChief Operating Officer766.5kN/A42
Ms. Kimberly McIntosh Bridges R.N, B.S.NSr. VP of Sales & Marketing - Vascular InterventionN/AN/A43
Ms. Donna Ford-SerbuSr. VP of Sales & Marketing for Lead Management503.42kN/A48
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to cross, prepare, and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads. The company's vascular intervention (VI) portfolio of VI devices includes laser and aspiration catheters; scoring balloon catheters, which supports catheters; and drug-coated balloon catheters. It also offers laser systems for use in various minimally invasive cardiovascular procedures; and sells, rents, and services its laser systems. The company's primary crossing products include Quick-Cross, Quick-Cross Select, and Quick-Cross Extreme support catheters; and coronary vascular intervention products comprise ELCA Laser Ablation Catheter and AngioSculpt scoring balloon catheters for crossing and vessel preparation, as well as QuickCat aspiration catheter for thrombus management. Its lead management product line comprises excimer laser sheaths, non-laser mechanical sheaths, and cardiac lead management accessories as well as Bridge occlusion balloon catheters for the removal of pacemaker and defibrillator cardiac leads. In addition, the company offers the Stellarex DCB platform that is designed to treat peripheral arterial disease. The company sells its products directly, as well as through its distributors in the United States, Canada, Europe, the Middle East, the Asia Pacific, Japan, China, Russia, Latin America, and Puerto Rico. The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, Colorado.

Corporate Governance

The Spectranetics Corporation’s ISS Governance QualityScore as of August 1, 2017 is 6. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.